Literature DB >> 14449808

Ethionamide: its passage into the cerebrospinal fluid in man.

I E HUGHES, H SMITH.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS/metabolism; TUBERCULOSIS, MENINGEAL/metabolism

Mesh：

Substances：

Year:  1962        PMID： 14449808     DOI： 10.1016/s0140-6736(62)91602-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

2.  Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs.

Authors:  M R Holdiness
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

3.  Ethionamide Pharmacokinetics/Pharmacodynamics-derived Dose, the Role of MICs in Clinical Outcome, and the Resistance Arrow of Time in Multidrug-resistant Tuberculosis.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Stellah G Mpagama; Shashikant Srivastava; Paula Bendet; Thearith Koeuth; Pooi S Lee; Scott K Heysell; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2018-11-28       Impact factor: 9.079

4.  Pharmacokinetics of ethionamide in children.

Authors:  S Thee; H I Seifart; B Rosenkranz; A C Hesseling; K Magdorf; P R Donald; H S Schaaf
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

6.  Population Pharmacokinetics and Dosing of Ethionamide in Children with Tuberculosis.

Authors:  Henrik Bjugård Nyberg; Heather R Draper; Anthony J Garcia-Prats; Stephanie Thee; Adrie Bekker; Heather J Zar; Andrew C Hooker; H Simon Schaaf; Helen McIlleron; Anneke C Hesseling; Paolo Denti
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.938
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.